Last updated on January 2019

A Safety Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e. Grand Mal) Seizures.


Brief description of study

The study is designed to evaluate the safety, tolerability and efficacy of two doses of pregabalin as add-on treatment in pediatric and adult subjects with Primary Generalized Tonic-Clonic (PGTC) seizures as compared to placebo. It is hypothesized that both doses of pregabalin will demonstrated superior efficacy when compared to placebo by reducing PGTC seizure frequency and that pregabalin will be safe and well tolerated.

Clinical Study Identifier: NCT01747915

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

NZOZ IGNIS dr n. med. Alicja Lobinska
Swidnik, Poland
  Connect »

Pfizer CT.gov Call Center

Instytut Medycyny Wsi im. Witolda Chodzki w Lublinie
Lublin, Poland
6.17miles
  Connect »

Pfizer CT.gov Call Center

Uniwersytecki Szpital Dzieciecy w Lublinie
Lublin, Poland
6.72miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.